Publications by Dr Tayyaba Khan - ePrints

Browsing publications by Dr Tayyaba Khan.

Newcastle Authors	Title	Year
Elizabeth Sconce Professor Ann Daly Dr Tayyaba Khan Dr Hilary Wynne Professor Farhad Kamali et al.	APOE genotype makes a small contribution to warfarin dose requirements	2006
Elizabeth Sconce Dr Tayyaba Khan Professor Ann Daly Dr Hilary Wynne Professor Farhad Kamali et al.	Apolipoprotein E polymorphisms do not make a clinically significant contribution to warfarin dose requirements	2006
Dr Hilary Wynne Dr Tayyaba Khan Dr Peter Avery Peter Wood Professor Farhad Kamali et al.	Dietary related plasma vitamin C concentration has no effect on anticoagulation response to warfarin	2006
Elizabeth Sconce Dr Tayyaba Khan Professor Ann Daly Dr Hilary Wynne Professor Farhad Kamali et al.	Simvastatin results in a lower warfarin dose requirement due to a reduced clearance of warfarin	2006
Elizabeth Sconce Dr Tayyaba Khan Professor Ann Daly Dr Hilary Wynne Professor Farhad Kamali et al.	The impact of simvastatin on warfarin disposition and dose requirements	2006
Dr Barry King Dr Tayyaba Khan Professor Farhad Kamali Professor Ann Daly	[abstract] CYP2C9 polymorphisms and haplotypes: correlation with warfarin dose and metabolism	2005
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Dr Patrick Kesteven Dr Peter Avery et al.	[abstract] Pfizer poster communication prize - The influence of patient age, CYP2C9 genotype and height on warfarin dose requirements	2005
Dr Tayyaba Khan Elizabeth Sconce Professor Farhad Kamali	Factors contributing to the stability of anticoagulation control and outcome of thromboembolic prophylaxis in the older population	2005
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Professor Farhad Kamali	Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation	2005
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Professor Farhad Kamali	Patients with unstable control have a poorer dietary intake of vitamin K compared with patients with stable control of anticoagulation	2005
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Dr Peter Avery Dr Barry King et al.	The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen	2005
Professor Farhad Kamali Dr Tayyaba Khan Dr Barry King Dr Patrick Kesteven Peter Wood et al.	Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin	2004
Dr Tayyaba Khan Dr Hilary Wynne Dr Peter Avery Dr Patrick Kesteven Professor Farhad Kamali et al.	Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin	2004
Professor Farhad Kamali Dr Tayyaba Khan Dr Barry King Professor Ann Daly Dr Hilary Wynne et al.	The impact of patient age and genetic polymorphism of CYP2C9 on warfarin dose requirements	2004
Dr Tayyaba Khan Professor Farhad Kamali Dr Patrick Kesteven Dr Peter Avery Dr Hilary Wynne et al.	The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation	2004
Dr Barry King Dr Tayyaba Khan Professor Farhad Kamali Professor Ann Daly	Upstream and coding region CYP2C9 polymorphisms: Correlation with warfarin dose and metabolism	2004
Dr Barry King Dr Tayyaba Khan Professor Farhad Kamali Professor Ann Daly	Novel CYP2C9 polymorphisms and their relationship to warfarin dose requirements	2003